NASDAQ:CNCE

Concert Pharmaceuticals Insider Trades

$4.01

0.00 (0.00 %)

(As of 05/7/2021 12:00 AM ET)

Add

Compare

Today's Range

$3.92

▼

$4.14

50-Day Range

$3.87

▼

$6.16

52-Week Range

$3.82

▼

$13.50

Volume206,283 shs

Average Volume448,291 shs

Market Capitalization$129.02 million

P/E RatioN/A

Dividend YieldN/A

Beta0.77

Concert Pharmaceuticals (NASDAQ:CNCE) Insider Buying and Selling Activity

Insider Ownership Percentage:	10.10%
Insider Buying (Last 12 Months):	$0.00
Insider Selling (Last 12 Months):	$285,625.14

Insider Buying and Selling by Quarter

Concert Pharmaceuticals (NASDAQ CNCE) Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
2/17/2021	Roger D Tung	CEO	Sell	13,480	$7.20	$97,056.00	808,578
2/16/2021	Jeffrey A Munsie	Insider	Sell	3,763	$7.32	$27,545.16	46,153
2/16/2021	Nancy Stuart	COO	Sell	6,049	$7.32	$44,278.68	173,280
6/22/2020	Nancy Stuart	COO	Sell	10,295	$11.34	$116,745.30	167,924
3/12/2020	Thomas G Auchincloss	Director	Buy	1,500	$8.52	$12,780.00	6,500
2/3/2020	Thomas G Auchincloss	Director	Buy	1,000	$10.91	$10,910.00	5,000
10/8/2019	Heek Christi Van	Director	Buy	5,000	$5.90	$29,500.00	5,000
8/8/2019	Peter Barton Hutt	Director	Sell	3,539	$10.31	$36,487.09	7,963
8/2/2019	Heek Christi Van	Director	Buy	5,000	$10.84	$54,200.00	5,000
6/10/2019	Bvf Partners L P/Il	Major Shareholder	Sell	386,289	$10.70	$4,133,292.30

11/15/2018	Richard Aldrich	Director	Buy	50,000	$11.83	$591,500.00	296,975
7/10/2018	Nancy Stuart	COO	Sell	31,418	$17.87	$561,439.66	116,085
4/17/2018	James V Cassella	Insider	Sell	10,582	$20.18	$213,544.76	30,000
2/1/2018	Richard Aldrich	Director	Sell	11,946	$20.89	$249,551.94	286,975
1/29/2018	Richard Aldrich	Director	Sell	18,054	$20.63	$372,454.02	286,975
1/26/2018	Richard Aldrich	Director	Sell	5,000	$20.46	$102,300.00	286,975
1/24/2018	Richard Aldrich	Director	Sell	30,000	$19.68	$590,400.00	286,975
1/22/2018	Richard Aldrich	Director	Sell	10,000	$19.55	$195,500.00	286,975
1/19/2018	Richard Aldrich	Director	Sell	30,000	$19.35	$580,500.00	286,975
1/16/2018	Richard Aldrich	Director	Sell	31,236	$19.14	$597,857.04	286,975
12/19/2017	Value Fund L P Biotechnology	Insider	Sell	1,282,856	$26.65	$34,188,112.40
12/4/2017	Ronald W Barrett	Director	Sell	14,156	$24.70	$349,653.20	3,539
10/19/2017	Value Fund L P Biotechnology	Insider	Buy	331,916	$15.84	$5,257,549.44
9/14/2017	Ryan Lynch	Insider	Sell	3,500	$14.51	$50,785.00	9,500
5/12/2016	Thomas G Auchincloss	Director	Buy	2,000	$10.11	$20,220.00	2,000
5/11/2016	Roger D Tung	CEO	Buy	19,610	$10.55	$206,885.50	538,965
12/16/2015	Wilfred E Jaeger	Director	Sell	10,360	$19.57	$202,745.20
12/15/2015	Wilfred E Jaeger	Director	Sell	54,572	$20.10	$1,096,897.20
12/14/2015	Pauline Mcgowan	VP	Sell	498	$20.07	$9,994.86
12/14/2015	Wilfred E Jaeger	Director	Sell	3,922	$20.09	$78,792.98
11/9/2015	Ronald W. Barrett	Director	Sell	17,699	$22.27	$394,156.73
11/2/2015	Nancy Stuart	COO	Sell	23,216	$24.29	$563,916.64	25,004
9/18/2015	Robert Silverman	VP	Sell	10,000	$20.00	$200,000.00	10,000
9/10/2015	Wilfred E Jaeger	Director	Sell	120,000	$18.22	$2,186,400.00
8/18/2015	Wilfred E Jaeger	Director	Sell	760,000	$15.81	$12,015,600.00
8/13/2015	Wilfred E Jaeger	Director	Sell	92,215	$16.75	$1,544,601.25
8/12/2015	Wilfred E Jaeger	Director	Sell	97,785	$17.49	$1,710,259.65
6/8/2015	Robert Silverman	VP	Sell	5,000	$16.35	$81,750.00
3/11/2015	Nancy Stuart	COO	Sell	46,430	$15.00	$696,450.00
3/11/2015	Pauline Mcgowan	VP	Sell	5,973	$16.00	$95,568.00
3/10/2015	Pauline Mcgowan	VP	Sell	22,122	$13.90	$307,495.80
11/18/2014	Three Arch Management Iv, L.L.	Director	Sell	250,000	$12.29	$3,072,500.00
2/20/2014	Skyline Venture Partners Quali	Major Shareholder	Buy	150,000	$14.00	$2,100,000.00
2/19/2014	Life Science Ventures Vi G Tvm	Director	Buy	89,000	$14.00	$1,246,000.00
2/19/2014	Plc Glaxosmithkline	Major Shareholder	Buy	35,000	$14.00	$490,000.00

(Data available from 1/1/2013 forward)

This page was last updated on 5/9/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Your Ultimate Investing Toolkit

Just $1.00 for your first month.

Concert Pharmaceuticals Insider Trades

Adding

Adding

Adding Concert Pharmaceuticals, Inc.

Insider Trades

Concert Pharmaceuticals (NASDAQ:CNCE) Insider Buying and Selling Activity

Insider Buying and Selling by Quarter

Concert Pharmaceuticals (NASDAQ CNCE) Insider Trading History

30 Days of MarketBeat All Access for $1.00

Resources

Premium Research Tools

Market Data and Calendars

Investing Education and Resources